A letter summarising the main recommendations from the WHO ACT-Accelerator Ethics & Governance Working Group on ethics surrounding vaccine trials has been published in Nature Medicine.

The Access to COVID-19 Tools (ACT) Accelerator is a global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines. Its international Ethics & Governance Working Group is co-chaired by Jonathan Wolff, Alfred Landecker Professor of Values and Public Policy, and has recently published some ethical consideration for vaccine trials.